Source: International Congress 2015 – Asthma and lung immunology
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Marina Karakina (Yekaterinburg, Russian Federation), Marina Karakina, Grigory Tsaur, Irina Tuzankina, Eugeny Beltukov. Are non-cystic fibrosis bronchiectasis a result of primary antibody deficiency?. Eur Respir J 2015; 46: Suppl. 59, 1099

Member's Comments

No comment yet.

Related content which might interest you: Non- cystic fibrosis bronchiectasis in primary antibody deficiency patients Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Two-compartment model of gas mixing in patients with asthma and cystic fibrosis Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 Immunoproteasome expression in pulmonary fibrosis Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE) Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation? Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Management and prevention of non-cystic fibrosis bronchiectasis Source: International Congress 2015 – PG9 Lower respiratory tract infection in children Year: 2015 Vitamin D serum level and pulmonary exacerbations in children with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Assessment of the work of breathing (sWOB) within different functional and genetic groups in patients with cystic fibrosis (CF) Source: Annual Congress 2013 –New perspectives of lung function assessment in children Year: 2013 Lung clearance index during pulmonary exacerbation in school-age children with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Annual change of LCI among patients with cystic fibrosis Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016 Steroid sparing effect of anti-IgE antibody in allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Bronchiectasis: epidemiology and causes Source: Eur Respir Mon 2011; 52: 1-10 Year: 2011 Agreement between the lung clearance index and bronchiectasis detected via chest computed tomography in infants and children with cystic fibrosis (CF) Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Physiology of the lung in idiopathic pulmonary fibrosis Source: Eur Respir Rev, 27 (147) 170062; 10.1183/16000617.0062-2017 Year: 2018 Lung clearance index predicts pulmonary exacerbations in cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 A new risk factor predicts ABPA in patients with cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 International validation of FACED score in 672 patients with non-cystic fibrosis bronchiectasis Source: International Congress 2016 – Clinical update on bronchiectasis Year: 2016 Cystic fibrosis Source: Respipedia Article Year: 2018 Anti-parietal cell autoimmunity in IPF patients Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016